Literature DB >> 20863668

Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.

Martin G Kees1, Justus W Hilpert, Carsten Gnewuch, Frieder Kees, Stephan Voegeler.   

Abstract

Vancomycin (VAN) dosing requires adjustment to renal function, which is often estimated using the Cockcroft-Gault formula; however, its precision is poor in Intensive Care Unit (ICU) patients. VAN clearance (CL(Van)) during continuous infusion was prospectively determined in 25 ICU patients [14 male, 11 female; age range 31-82 years; body mass index (BMI) 16.5-41.5 kg/m²; Acute Physiology and Chronic Health Evaluation (APACHE) II score at admission 8-36; creatinine clearance 25-195 mL/min] and its correlation with measured creatinine clearance (CL(Crea)), estimated creatinine clearance using the Cockcroft-Gault formula (CL(CG)) and estimated glomerular filtration rate according to Hoek's formula based on serum cystatin C (GFR(Hoek)) was investigated. The correlation between CL(Van) and CL(Crea) was very good (r²=0.88), but it was rather poor with CL(CG) (r² = 0.37) and was acceptable with GFR(Hoek) (r² = 0.70). For VAN dose adjustments in ICU patients, determination of cystatin C may be an interesting and practical alternative to measured CL(Crea), whereas the Cockcroft-Gault formula should be used with caution.
Copyright © 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863668     DOI: 10.1016/j.ijantimicag.2010.07.015

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

1.  Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing.

Authors:  Mathias W Pletz; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-04-20       Impact factor: 17.440

2.  Single-Center Pharmacokinetic Study and Simulation of a Low Meropenem Concentration in Brain-Dead Organ Donors.

Authors:  Jae-Myeong Lee; Joo Won Lee; Tae Seok Jeong; Eun Sook Bang; So Hee Kim
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

3.  Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.

Authors:  Guo Yu; Guo-Fu Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-02       Impact factor: 2.441

Review 4.  Implications of augmented renal clearance in critically ill patients.

Authors:  Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

Review 5.  Cystatin C as a potential biomarker for dosing of renally excreted drugs.

Authors:  Nguessan Aimé Brou; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

6.  Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients.

Authors:  Herbert D Spapen; Karin Janssen van Doorn; Marc Diltoer; Walter Verbrugghe; Rita Jacobs; Nadia Dobbeleir; Patrick M Honoré; Philippe G Jorens
Journal:  Ann Intensive Care       Date:  2011-07-19       Impact factor: 6.925

7.  Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patients.

Authors:  Thomas Steinke; Stefan Moritz; Stefanie Beck; Carsten Gnewuch; Martin G Kees
Journal:  BMC Anesthesiol       Date:  2015-04-28       Impact factor: 2.217

8.  Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.

Authors:  João Pedro Baptista; Jason A Roberts; Eduardo Sousa; Ricardo Freitas; Nuno Deveza; Jorge Pimentel
Journal:  Crit Care       Date:  2014-12-05       Impact factor: 9.097

9.  A Novel Method for the Determination of Vancomycin in Serum by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Application in Patients with Diabetic Foot Infections.

Authors:  Min Liu; Zhi-Hui Yang; Guo-Hui Li
Journal:  Molecules       Date:  2018-11-10       Impact factor: 4.411

10.  Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study.

Authors:  Erin N Frazee; Andrew D Rule; Sandra M Herrmann; Kianoush B Kashani; Nelson Leung; Abinash Virk; Nikolay Voskoboev; John C Lieske
Journal:  Crit Care       Date:  2014-05-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.